(Q39770880)

English

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

object named as

Paul J Dyson

9

0 references

Maria Pia Rigobello

6

object named as

Maria Pia Rigobello

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Alberto Bindoli

7

object named as

Alberto Bindoli

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Francesca Sorrentino

3

object named as

Francesca Sorrentino

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Elena Vergara

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Olivier Zava

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Elena Cerrada

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Mariano Laguna

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

96-102

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

21 January 2018

New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemistry. Metal-based therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Ruthenium antimetastatic agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Metal-based antitumour drugs in the post genomic era.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-cancer potential of gold complexes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Gold derivatives for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Gold-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

New trends for metal complexes with anticancer activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

[Ru(η6-p-cymene)Cl2(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of Structural Variation on the Anticancer Activity of RAPTA-Type Complexes: ptn versus pta

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

In Vitro Evaluation of Rhodium and Osmium RAPTA Analogues: The Case for Organometallic Anticancer Drugs Not Based on Ruthenium

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Classical and Non-Classical Ruthenium-Based Anticancer Drugs: Towards Targeted Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical behavior and in vitro activity of mixed phosphine gold(I) compounds on melanoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Metallothioneins and platinum(II) anti-tumor compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of Rat Cytosolic Thioredoxin Reductase Is Strongly Decreased bytrans-[Bis(2-amino-5- methylthiazole)tetrachlororuthenate(III)]: First Report of Relevant Thioredoxin Reductase Inhibition for a Ruthenium Compound

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]− to human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

The thioredoxin system—From science to clinic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new photosensitizing precursors of protoporphyrin IX in cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Rat liver thioredoxin and thioredoxin reductase: purification and characterization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900370

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.200900370

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

release_pn6ihuvorngovma7vin3b2t4vq

1 reference

https://api.fatcat.wiki/v0/release/pn6ihuvorngovma7vin3b2t4vq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39770880&oldid=2090153256"